rivaroxaban and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

rivaroxaban has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for rivaroxaban and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

Article	Year
Network meta-analysis: a new analysis tool of the experimental evidence. Minerva medica, 2019, Volume: 110, Issue:2 Topics: Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Dabigatran; Dasatinib; Data Interpretation, Statistical; Humans; Imatinib Mesylate; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Network Meta-Analysis; Pyrimidines; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Warfarin	2019

Article

Year

Network meta-analysis: a new analysis tool of the experimental evidence.

Minerva medica, 2019, Volume: 110, Issue:2

Topics: Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Dabigatran; Dasatinib; Data Interpretation, Statistical; Humans; Imatinib Mesylate; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Network Meta-Analysis; Pyrimidines; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Warfarin

2019